Patents by Inventor Adrian Tersteegen

Adrian Tersteegen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090111838
    Abstract: The invention relates to novel 6-arylamino-5-cyano-4-pyrimidinones of formula (I) methods for the production thereof, and the use thereof for producing medicaments utilized for improving awareness, concentration, learning capacity, and/or retentiveness of memory. Said compounds (I) show activity as PDE9 inhibitors.
    Type: Application
    Filed: December 19, 2008
    Publication date: April 30, 2009
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Martin HENDRIX, Lars BARFACKER, Bettina BEYREUTHER, Ulrich EBERT, Christina ERB, Frank-Thorsten HAFNER, Heike HECKROTH, Yan-Hong LIU, Dagmar KARTHAUS, Adrian TERSTEEGEN, Franz-Josef VAN DER STAAY, Marja VAN KAMPEN
  • Patent number: 7488733
    Abstract: The invention relates to novel 6-arylamino-5-cyano-4-pyrimidinones of formula (I) methods for the production thereof, and the use thereof for producing medicaments utilized for improving awareness, concentration, learning capacity, and/or retentiveness of memory. Said compounds (I) show activity as PDE9 inhibitors.
    Type: Grant
    Filed: June 16, 2004
    Date of Patent: February 10, 2009
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Martin Hendrix, Lars Bärfacker, Bettina Beyreuther, Ulrich Ebert, Christina Erb, Frank-Thorsten Hafner, Heike Heckroth, Yan-Hong Liu, Dagmar Karthaus, Adrian Tersteegen, Franz-Josef van der Staay, Marja van Kampen
  • Publication number: 20080255118
    Abstract: The invention relates to novel cyanopyrimidinones, process for their preparation, and the use thereof for producing medicaments for improving perception, concentration, learning and/or memory.
    Type: Application
    Filed: December 31, 2004
    Publication date: October 16, 2008
    Applicant: Bayer HealthCare AG
    Inventors: Martin Hendrix, Lars Barfacker, Heike Heckroth, Dagmar Karthaus, Adrian Tersteegen
  • Publication number: 20070161662
    Abstract: The invention relates to novel 6-arylmethyl-substituted pyrazolopyrimidines, process for their preparation and their use for producing medicaments for improving perception, concentration, learning and/or memory.
    Type: Application
    Filed: April 27, 2004
    Publication date: July 12, 2007
    Applicant: Bayer HealthCare AG
    Inventors: Martin Hendrix, Lars Barfacker, Christina Erb, Frank-Thorsten Hafner, Heike Heckroth, Dagmar Karthaus, Adrian Tersteegen, Franz-Josef van der Staay, Marja van Kampen
  • Publication number: 20070105876
    Abstract: The invention relates to novel 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines, process for their preparation and their use for producing medicaments for improving perception, concentration, learning and/or memory.
    Type: Application
    Filed: April 28, 2004
    Publication date: May 10, 2007
    Inventors: Martin Hendrix, Lars Barfacker, Christina Erb, Frank-Thorsten Hafner, Heike Heckroth, Dagmar Karthaus, Adrian Tersteegen, Franz-Josef van der Staay, Marja van Kampen
  • Publication number: 20070105881
    Abstract: The invention relates to novel 6-arylamino-5-cyano-4-pyrimidinones of formula (I) methods for the production thereof, and the use thereof for producing medicaments utilized for improving awareness, concentration, learning capacity, and/or retentiveness of memory. Said compounds (I) show activity as PDE9 inhibitors.
    Type: Application
    Filed: June 16, 2004
    Publication date: May 10, 2007
    Applicant: Bayer HealthCare AG
    Inventors: Martin Hendrix, Lars Barfacker, Bettina Beyreuther, Ulrich Ebert, Christina Erb, Frank-Thorsten Hafner, Heike Heckroth, Yan-Hong Liu, Dagmar Karthaus, Adrian Tersteegen, Franz-Josef van der Staay, Marja van Kampen
  • Patent number: 7202243
    Abstract: The invention relates to new substituted imidazotriazines, processes for their preparation and their use for the production of medicaments for the treatment and/or prophylaxis of cancer and neurodegenerative disorders, in particular of Parkinson's disease and of schizophrenia.
    Type: Grant
    Filed: June 25, 2003
    Date of Patent: April 10, 2007
    Assignee: Bayer HealthCare AG
    Inventors: Martin Hendrix, David Brückner, Arno Friedl, Irene Gerlach, Volker Hinz, Jörg Keldenich, Frank Mauler, Maria Niewöhner, legal representative, Dagmar Karthaus, Karl-Heinz Schlemmer, Adrian Tersteegen, Özkan Yalkinoglu, Ulrich Niewöhner, deceased
  • Publication number: 20060166993
    Abstract: The invention relates to new substituted imidazotriazines, processes for their preparation and their use for the production of medicaments for the treatment and/or prophylaxis of cancer and neurodegenerative disorders, in particular of Parkinson's disease and of schizophrenia.
    Type: Application
    Filed: June 25, 2003
    Publication date: July 27, 2006
    Applicant: Bayer Healthcare AG
    Inventors: Martin Hendrix, David Bruckner, Arno Friedl, Irene Gerlach, Volker Hinz, Jorg Keldenich, Frank Mauler, Ulrich Niewohner, Maria Niewohner, Dagmar Karthaus, Karl-Heinz Schlemmer, Adrian Tersteegen, Ozkan Yalkinoglu
  • Publication number: 20060111372
    Abstract: The invention relates to novel alkyl-substituted pyrazolopyrimidines, process for their preparation, and the use thereof for producing medicaments for improving perception, concentration, learning and/or memory.
    Type: Application
    Filed: August 13, 2003
    Publication date: May 25, 2006
    Applicant: Bayer Healthcare AG
    Inventors: Martin Hendrix, Frank-Gerhard Boss, Nils Burkhard, Christina Erb, Adrian Tersteegen, Marja Van Kampen
  • Publication number: 20060106035
    Abstract: The invention relates to novel phenyl-substituted pyrazolopyrimidines, process for their preparation, and their use for producing medicaments for improving perception, concentration, learning and/or memory.
    Type: Application
    Filed: August 12, 2003
    Publication date: May 18, 2006
    Inventors: Martin Hendrix, Frank-Gerhard Boss, Nils Burkhardt, Christina Erb, Adrian Tersteegen, Marja Van Kampen
  • Patent number: 6936609
    Abstract: The invention relates to new imidazotriazines, processes for their preparation, and their use for the production of medicaments for the treatment and/or prophylaxis of neurodegenerative disorders, in particular Parkinson's disease.
    Type: Grant
    Filed: June 10, 2002
    Date of Patent: August 30, 2005
    Assignee: Bayer HealthCare AG
    Inventors: Jens-Kerim Ergüden, Marcus Bauser, Nils Burkhardt, Dietmar Flubacher, Arno Friedl, Irene Gerlach, Volker Hinz, Reinhard Jork, Paul Naab, Maria Theresia Niewöhner, Thorsten Oliver Repp, Karl-Heinz Schlemmer, Jürgen Stoltefuss, David Brückner, Martin Hendrix, Dagmar Schauss, Adrian Tersteegen, Ulrich Niewöhner
  • Publication number: 20040249148
    Abstract: The invention relates to new imidazotriazines, processes for their preparation, and their use for the production of medicaments for the treatment and/or prophylaxis of neurodegenerative disorders, in particular Parkinson's disease.
    Type: Application
    Filed: June 25, 2004
    Publication date: December 9, 2004
    Inventors: Jens-Kerim Erguden, Marcus Bauser, Nils Burkhardt, Dietmar Flubacher, Arno Friedl, Irene Gerlach, Volker Hinz, Reinhard Jork, Paul Naab, Ulrich Niewohner, Maria Theresia Niewohner, Thorsten Oliver Repp, Karl-Heinz Schlemmer, Jurgen Stoltefuss, David Bruckner, Martin Hendrix, Dagmar Schauss, Adrian Tersteegen